Iohexol
- Atc Codes:V08AB02
- CAS Codes:66108-95-0
- PHARMGKB ID:66108-95-0
Table of contents
- Brand Names
- Chemistry
- Pharmacologic Category
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Drug Interactions
- Dosage
Brand Names
Europe
Austria: Accupaque, Omnipaque; Belgium: Omnipaque; Bulgaria: Omnipaque; Cyprus: Omnipaque; Czech Republic: Omnipaque; Denmark: Omnipaque; Estonia: Omnipaque; Finland: Omnipaque; France: Omnipaque; Germany: Accupaque, Iohexagita, Iohexol, Omnipaque; Greece: Accupaque, Omnipaque; Hungary: Omnipaque; Ireland: Omnipaque; Italy: Omnipaque; Latvia: Omnipaque; Lithuania: Omnipaque; Luxembourg: Omnipaque; Malta: Omnipaque; Netherlands: Omnipaque; Poland: Omnipaque; Romania: Omnipaque; Slovakia: Omnipaque; Spain: Iohexol, Omnipaque, Omnitrast; Sweden: Omnipaque.
North America
Canada: Omnipaque; USA: Omnipaque.
Asia
Japan: Iohexol, Iopaque, Iosol, Ioverin, Moiopaque, Omnipaque.
Drug combinations
Chemistry
Iohexol: C~19~H~26~I~3~N~3~O~9~. Mw: 821.14. (1) 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo; (2) N,N’-Bis(2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide. CAS-66108-95-0 (1980).
Pharmacologic Category
Diagnostic Agents; Imaging Agents; Iodinated Contrast Media. Radiological/Contrast Media (Nonionic, Low Osmolality). (ATC-Code: V08AB02).
Mechanism of action
Therapeutic use
Myelography. Contrast enhancement for computerized tomography. Angiocardiography, aortography, digital subtraction angiography, peripheral arteriography, excretory urography. Contrast enhancement for computed tomographic imaging (intravascular). Arthrography, GI tract examination, hysterosalpingography, pancreatography, cholangiopancreatography, herniography, cystourethrography, enhanced computed tomography of abdomen (oral/body cavity).
Pregnancy and lactiation implications
Fetal harm not observed in animal studies. In general, iodinated contrast media agents are avoided during pregnancy unless essential for diagnosis. Not recommended in nursing women.
Unlabeled use
Contraindications
Hypersensitivity to iohexol or any component of the formulation.